LYM-2033 FL (#355)
Laufzeit: 01.01.2010 - 31.12.2010
Kurzfassung
A randomized, open-label, multicenter phase II study of Velcade with Fludarabine in comparison to Rituximab with Fludarabine in follicular lymphoma subjects previously treated with Rituximab
